Is Acrivon Therapeutics, Inc. Common Stock (ACRV) a Buy, Sell, or Hold?
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV
$2.13 USD
$0.15 (7.58%)
- Volume
- 1.02M
- Average Volume
- 577.41K
- Market Capitalization
- $67.21M
- P/E Ratio
- -1.07
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $3.56
- Year Low
- $1.20
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.98
Analyst Rating
Neutral
3 Rating Score
UPSIDE/DOWNSIDE
-89.4% DOWNSIDE
$20.00 Price Target
UPSIDE/DOWNSIDE HIGH
-92.9% DOWNSIDE
$30.00 Price Target High
UPSIDE/DOWNSIDE LOW
-87.5% DOWNSIDE
$17.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| BMO Capital | Etzer Darout | $27 | $7.92 | 2024-11-14 07:53 AM | 240.9% |
| BMO Capital | Etzer Darout | $28 | $8.91 | 2024-09-16 03:19 AM | 214.3% |
| Oppenheimer | Matthew Biegler | $18 | $7.26 | 2024-08-13 11:06 AM | 147.9% |
| Oppenheimer | Matthew Biegler | $21 | $8.36 | 2024-05-14 10:49 AM | 151.2% |
| H.C. Wainwright | Emily Bodnar | $22 | $8.345 | 2024-05-14 07:57 AM | 163.6% |
| BMO Capital | Etzer Darout | $25 | $8.51 | 2024-05-14 05:24 AM | 193.8% |
| Piper Sandler | Joseph Catanzaro | $30 | $9.2 | 2024-04-25 05:47 AM | 226.1% |
| JMP Securities | Silvan Tuerkcan | $17 | $9.5 | 2024-04-25 02:27 AM | 78.9% |
| H.C. Wainwright | Emily Bodnar | $20 | $7.185 | 2024-03-28 09:14 AM | 178.4% |